CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Technological advancements in cell isolation
4.1.2. Increasing focus on personalised medicine
4.1.3. Growing biotechnology and biopharmaceutical industries
4.1.4. Rising number of patients who have cancer and infectious diseases
4.1.5. Increasing government funding for cell-based research
4.2. Market Restraints & Challenges
4.2.1. Ethical issues regarding embryonic stem cell isolation
4.2.2. The high cost of cell isolation instruments
4.3. Market Opportunities
4.3.1. Huge developments in stem cell research
4.3.2. Emerging markets and advent of microfluidics
CHAPTER 5. GLOBAL CELL ISOLATION MARKET – BY PRODUCT
5.1. Consumables
5.1.1. Reagents, Kits, Media, and Sera
5.1.2. Beads
5.1.3. Disposables
5.2. Instruments
5.2.1. Centrifuges
5.2.2. Flow Cytometers
5.2.3. Magnetic-Activated Cell Separator Systems
5.2.3.1. Manual Magnetic-Activated Cell Separator Systems
5.2.3.2. Automated Magnetic-Activated Cell Separator Systems
5.2.4. Filtration Systems
CHAPTER 6. GLOBAL CELL ISOLATION MARKET – BY CELL TYPE
6.1. Human Cells
6.1.1. Differentiated Cells
6.1.2. Stem Cells
6.2. Animal Cells
CHAPTER 7. GLOBAL CELL ISOLATION MARKET – BY TECHNIQUE
7.1. Centrifugation-Based Cell Isolation
7.2. Surface Marker-Based Cell Isolation
7.3. Filtration-Based Cell Isolation
CHAPTER 8. GLOBAL CELL ISOLATION MARKET – BY APPLICATION
8.1. Biomolecule Isolation
8.2. Cancer Research
8.3. Stem Cell Research
8.4. Tissue Regeneration
8.5. In Vitro Diagnostics
8.6. Therapeutics
CHAPTER 9. GLOBAL CELL ISOLATION MARKET – BY END USER
9.1. Research Laboratories and Institutes
9.2. Hospitals and Diagnostic Laboratories
9.3. Cell Banks
9.4. Biotechnology and Biopharmaceutical Companies
CHAPTER 10. GLOBAL CELL ISOLATION MARKET - BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11. GLOBAL CELL ISOLATION MARKET - COMPANY PROFILES
11.1. Thermo Fisher Scientific Inc.
11.2. Miltenyi Biotech
11.3. Pluriselect Life Science
11.4. Stemcell Technologies Inc.
11.5. Terumo BCT (A Subsidiary of Terumo Corporation)
11.6. Bio-Rad Laboratories, Inc.
11.7. Beckman Coulter, Inc.
11.8 Becton, Dickinson and Company
11.9 GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
11.10 Merck Group
11.11. BD Biosciences
11.12. Danaher Corporation
11.13. PerkinElmer Inc.
11.14. Abbott Laboratories
CHAPTER 12. GLOBAL CELL ISOLATION MARKET - COMPETITIVE
LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13. MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14. APPENDIX
14.1. List of Tables
14.2. List of Figures
